Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01052051 · ClinicalTrials.gov registry record · Phase 2

Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women

A Phase 2 study, sponsored by Creighton University.

Completed
Registry status
Phase 2
Development phase
2,303
Enrollment target

NCT01052051: Completed Phase 2 study, sponsored by Creighton University.

NCT01052051 is a Phase 2 study that has completed, run by Creighton University. The registered enrollment target is 2,303 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1632% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01052051, a Phase 2 study, has completed, sponsored by Creighton University.

COMPLETED
Registry status
Phase 2
Development phase
2,303 participants
Enrollment target

Study Summary

To determine the effect of increasing serum 25(OH)D from prevailing levels with vitamin D3 supplementation, while maintaining adequate calcium intake, on incidence of all-type cancer in a population sample of healthy postmenopausal women.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D3
  • DIETARY_SUPPLEMENT Calcium carbonate

Trial Details

FieldValue
Enrollment Target 2,303 participants
Start Date 2009-06
Est. Completion 2015-08
Phase Phase 2
Creighton University

98 total trials

What the finished NCT01052051 record still lists

NCT01052051 is an interventional study that assigns participants to a tested intervention. Its 2,303 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (1632% higher).

The record links to 0 conditions, and to 2 interventions - of which Vitamin D3 is the first listed.

NCT01052051 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01052051 about?

NCT01052051 is a clinical study titled "Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women". To determine the effect of increasing serum 25(OH)D from prevailing levels with vitamin D3 supplementation, while maintaining adequate calcium intake, on incidence of all-type cancer in a population sample of healthy postmenopausal women.

What is the current status of trial NCT01052051?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 2,303 participants. The study started on 2009-06. Estimated completion is 2015-08.

What interventions are being tested in trial NCT01052051?

The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Calcium carbonate (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01052051?

This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01052051's enrollment target sits among peer trials

2,303 8th of 2000 higher than 1,993 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04124120 · 2,300 participants · NA

    Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

  • NCT05237258 · 2,300 participants · NA

    Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

  • NCT05732623 · 2,300 participants

    Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

  • NCT05759988 · 2,300 participants · NA

    Cervical Ripening as an Outpatient Method Using the Foley (COMFORT)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01052051, the US trial registry maintained by the National Library of Medicine. NCT01052051 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.